4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid

C73H89N2O11S2+ — CID 134271443

IUPAC4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid
SMILESCC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc(C(=O)Oc4ccc5c(c4)CCC4C5CCC5(C)C(O)CCC45)cc3C2(C)C)=[N+](CCCCS(=O)O)c2ccc(C(=O)Oc3ccc4c(c3)CCC3C4CCC4(C)C(O)CCC34)cc21
InChIInChI=1S/C73H88N2O11S2/c1-70(2)60-44-48(68(78)85-50-22-26-52-46(42-50)18-24-56-54(52)34-36-72(5)58(56)28-32-66(72)76)20-30-62(60)74(38-12-14-40-87(80)81)64(70)16-10-8-7-9-11-17-65-71(3,4)61-45-49(21-31-63(61)75(65)39-13-15-41-88(82,83)84)69(79)86-51-23-27-53-47(43-51)19-25-57-55(53)35-37-73(6)59(57)29-33-67(73)77/h7-11,16-17,20-23,26-27,30-31,42-45,54-59,66-67,76-77H,12-15,18-19,24-25,28-29,32-41H2,1-6H3,(H-,80,81,82,83,84)/p+1
InChIKeyFTDYGTVZSUGRQJ-UHFFFAOYSA-O
MW1234.65 g/mol
LogP13.96
Rot. Bonds18

About 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid

4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid (PubChem CID 134271443) has the molecular formula C73H89N2O11S2+ and a molecular weight of 1234.65 g/mol. Its IUPAC name is 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid.

Molecular Properties

Compound Name4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid
PubChem CID134271443
Molecular FormulaC73H89N2O11S2+
Molecular Weight1234.65 g/mol
Exact Mass1233.59
IUPAC Name4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid
SMILESCC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc(C(=O)Oc4ccc5c(c4)CCC4C5CCC5(C)C(O)CCC45)cc3C2(C)C)=[N+](CCCCS(=O)O)c2ccc(C(=O)Oc3ccc4c(c3)CCC3C4CCC4(C)C(O)CCC34)cc21
InChIInChI=1S/C73H88N2O11S2/c1-70(2)60-44-48(68(78)85-50-22-26-52-46(42-50)18-24-56-54(52)34-36-72(5)58(56)28-32-66(72)76)20-30-62(60)74(38-12-14-40-87(80)81)64(70)16-10-8-7-9-11-17-65-71(3,4)61-45-49(21-31-63(61)75(65)39-13-15-41-88(82,83)84)69(79)86-51-23-27-53-47(43-51)19-25-57-55(53)35-37-73(6)59(57)29-33-67(73)77/h7-11,16-17,20-23,26-27,30-31,42-45,54-59,66-67,76-77H,12-15,18-19,24-25,28-29,32-41H2,1-6H3,(H-,80,81,82,83,84)/p+1
InChIKeyFTDYGTVZSUGRQJ-UHFFFAOYSA-O
XLogP13.96
TPSA190.98 Ų
H-Bond Donors4
H-Bond Acceptors10
Rotatable Bonds18
Heavy Atoms88
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 5001234.65
LogP ≤ 513.96
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1010

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'phenol_ester', 'substructure': 'N/A'}, {'alert_name': 'polyene', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'}, {'alert_name': 'sulfinic_acid', 'substructure': 'N/A'}

Analyze 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid?
The IUPAC name of 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid (CID 134271443) is 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid.
What is the SMILES notation for 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid?
The canonical SMILES for 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid is CC1(C)C(/C=C/C=C/C=C/C=C2\N(CCCCS(=O)(=O)O)c3ccc(C(=O)Oc4ccc5c(c4)CCC4C5CCC5(C)C(O)CCC45)cc3C2(C)C)=[N+](CCCCS(=O)O)c2ccc(C(=O)Oc3ccc4c(c3)CCC3C4CCC4(C)C(O)CCC34)cc21.
What is the InChIKey of 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid?
The InChIKey is FTDYGTVZSUGRQJ-UHFFFAOYSA-O. The full InChI is InChI=1S/C73H88N2O11S2/c1-70(2)60-44-48(68(78)85-50-22-26-52-46(42-50)18-24-56-54(52)34-36-72(5)58(56)28-32-66(72)76)20-30-62(60)74(38-12-14-40-87(80)81)64(70)16-10-8-7-9-11-17-65-71(3,4)61-45-49(21-31-63(61)75(65)39-13-15-41-88(82,83)84)69(79)86-51-23-27-53-47(43-51)19-25-57-55(53)35-37-73(6)59(57)29-33-67(73)77/h7-11,16-17,20-23,26-27,30-31,42-45,54-59,66-67,76-77H,12-15,18-19,24-25,28-29,32-41H2,1-6H3,(H-,80,81,82,83,84)/p+1.
What are the key properties of 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid?
4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid has a molecular weight of 1234.65 g/mol, XLogP of 13.96, 18 rotatable bonds, 4 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[(2Z)-5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-2-[(2E,4E,6E)-7-[5-[(17-hydroxy-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl)oxycarbonyl]-3,3-dimethyl-1-(4-sulfinobutyl)indol-1-ium-2-yl]hepta-2,4,6-trienylidene]-3,3-dimethylindol-1-yl]butane-1-sulfonic acid is sourced from PubChem (CID 134271443), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).